<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">Transient ischemia</z:e> has been shown to damage the basal lamina of the cerebral microvasculature </plain></SENT>
<SENT sid="1" pm="."><plain>Other studies proved <z:chebi fb="0" ids="35664">statins</z:chebi> to be beneficial to non-cerebral microvessels </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to determine whether pravastatin pretreatment ameliorates microvascular basal lamina damage following <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Using the suture model, we subjected 15 rats to focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (3 h) and reperfusion (24 h) </plain></SENT>
<SENT sid="4" pm="."><plain>Rats received pravastatin (20 mg/kg/day) or saline for 4 weeks prior to the experiment </plain></SENT>
<SENT sid="5" pm="."><plain>The outcome was determined by a behavior test and the <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="6" pm="."><plain>Collagen type IV, a marker for an intact basal lamina, and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> extravasation were measured by Western blot analysis </plain></SENT>
<SENT sid="7" pm="."><plain>A ratio (in percentage) between ischemic and contralateral hemispheres was calculated </plain></SENT>
<SENT sid="8" pm="."><plain>Pravastatin pretreatment resulted in a significantly better neurological outcome and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size (15 +/- 0.5 and 59 +/- 10 mm(3), respectively) compared with controls (12.25 +/- 0.4 and 167 +/- 13 mm(3), respectively, P &lt; 0.01 for both) </plain></SENT>
<SENT sid="9" pm="."><plain>In controls, loss of collagen type IV was seen in the basal ganglia and in the cortex (43 +/- 4 and 64 +/- 5%, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>Pravastatin prevented significant collagen loss (basal ganglia: 106 +/- 17%; cortex: 112 +/- 14%, P &lt; 0.01 for both) and significantly reduced the <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> extravasation compared with controls in the basal ganglia (198 +/- 49 vs. 553 +/- 47%, P &lt; 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>Pravastatin pretreatment resulted in a reduction of microvascular basal lamina damage and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> extravasation following <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Pravastatin seems to protect the cerebral microvascular system </plain></SENT>
</text></document>